Prelude Therapeutics Incorporated Profile Avatar - Palmy Investing

Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select sol…

Biotechnology
US, Wilmington [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PRLD's Analysis
CIK: 1678660 CUSIP: 74065P101 ISIN: US74065P1012 LEI: - UEI: -
Secondary Listings
PRLD has no secondary listings inside our databases.